Porphyromonas gingivalis lipopolysaccharide weakly activates M1 and M2 polarized mouse macrophages but induces inflammatory cytokines

Infection and Immunity

Volumn 82, Issue 10, 2014, Pages 4190-4203

  Holden, James A ^a   Attard, Troy J ^a   Laughton, Katrina M ^a   Mansell, Ashley ^b   O'Brien Simpson, Neil M ^a   Reynolds, Eric C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; BACTERIUM LIPOPOLYSACCHARIDE; CD206 PROTEIN; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE KC; EOTAXIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YM 1 PROTEIN; CD86 PROTEIN, MOUSE; CYTOKINE; LIPOPOLYSACCHARIDE; NOS2 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; WHOLE CELL; ANIMAL; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS); UPREGULATION;

ANIMALS; ANTIGENS, CD40; ANTIGENS, CD86; ARGINASE; CELLS, CULTURED; CYTOKINES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PORPHYROMONAS GINGIVALIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84907096298     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02325-14     Document Type: Article

References (66)

1. Oliver RC, Brown LJ. 1993. Periodontal diseases and tooth loss. Periodontol. 2000 2:117-127. http://dx.doi.org/10.1111/j.1600-0757.1993 .tb00224.x.
2. Darveau RP. 2010. Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 8:481-490. http://dx.doi.org/10.1038/nrmicro2337.
3. Moskow BS, Polson AM. 1991. Histologic studies on the extension of the inflammatory infiltrate in human periodontitis. J. Clin. Periodontol. 18: 534-542. http://dx.doi.org/10.1111/j.1600-051X.1991.tb00086.x.
4. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511. http://dx.doi.org/10.1038/nri1391.
5. Hajishengallis G, Darveau RP, Curtis MA. 2012. The keystone-pathogen hypothesis. Nat. Rev. Microbiol. 10:717-725. http://dx.doi.org/10.1038/nrmicro2873.
6. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134- 144. http://dx.doi.org/10.1111/j.1600-051X.1998.tb02419.x.
7. Bainbridge BW, Coats SR, Darveau RP. 2002. Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. Ann. Periodontol. 7:29-37. http://dx.doi.org/10 .1902/annals.2002.7.1.29.
8. Gordon S, Taylor PR. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5:953-964. http://dx.doi.org/10.1038/nri1733.
9. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. 2009. Variable cell responses to P. gingivalis lipopolysaccharide. J. Dent. Res. 88:741-745. http://dx.doi.org/10.1177/0022034509341166.
10. Asai Y, Hashimoto M, Fletcher HM. 2005. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated. Infect. Immun. 73:2157-2157. http://dx.doi.org/10.1128/IAI.73.4.2157-2163.2005.
11. Hashimoto M, Asai Y, Ogawa T. 2004. Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. Int. Immunol. 16:1431-1437. http://dx.doi.org/10.1093/intimm /dxh146.
12. Jain S, Coats SR, Chang AM, Darveau RP. 2013. A novel class of lipoprotein lipase-sensitive molecules mediates TLR2 activation by Porphyromonas gingivalis. Infect. Immun. 81:1277-1286. http://dx.doi.org/10 .1128/IAI.01036-12.
13. Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, Miyake K, Akira S. 2002. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation fac-tor 88-dependent signaling pathway. Int. Immunol. 14:1325-1332. http: //dx.doi.org/10.1093/intimm/dxf097.
14. Coats SR, Reife RA, Bainbridge BW, Pham TT, Darveau RP. 2003. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect. Immun. 71:6799-6807. http://dx.doi.org/10.1128/IAI.71.12.6799 -6807.2003.
15. Herath TD, Darveau RP, Seneviratne CJ, Wang CY, Wang Y, Jin L. 2013. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts. PLoS One 8:e58496. http://dx.doi.org/10.1371/journal.pone .0058496.
16. Benoit M, Desnues B, Mege J-L. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181:3733-3739. http://dx.doi.org/10 .4049/jimmunol.181.6.3733.
17. Dalton D, Pitts-Meek S, Keshav S, Figari I, Bradley A, Stewart T. 1993. Multiple defects of immune cell function in mice with disrupted interferongamma genes. Science 259:1739-1742. http://dx.doi.org/10.1126/science .8456300.
18. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. 2006. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80:1298-1298. http://dx.doi.org/10.1189/jlb.0406249.
19. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23:901-944. http://dx.doi.org/10.1146/annurev.immunol.23 .021704.115816.
20. Stein M, Keshav S, Harris N, Gordon S. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287-292. http://dx.doi.org/10.1084/jem.176.1.287.
21. Doyle AG, Herbein G, Montaner LJ, Mintyo AJ, Caputo D, Gordon S, Minty AJ, Caput D, Ferrara P. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24:1441-1445. http://dx.doi.org/10.1002/eji.1830240630.
22. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533-6544. http://dx.doi.org/10.4049/jimmunol.167.11.6533.
23. Gharib SA, Johnston LK, Huizar I, Birkland TP, Hanson J, Wang Y, Parks WC, Manicone AM. 2014. MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis. J. Leukoc. Biol. 95:9-18. http://dx.doi.org/10.1189/jlb.1112587.
24. Ho VW, Sly LM. 2009. Derivation and characterization of murine alternatively activated (M2) macrophages. Methods Mol. Biol. 531:173-185. http://dx.doi.org/10.1007/978-1-59745-396-7_12.
25. Chavrier C, Couble ML, Hartmann D, Grimaud JA, Magloire H. 1987. Immunohistochemical study of types I, III and IV collagen in fibrosis of diseased gingiva during chronic periodontitis: a light and electron microscopic study. J. Periodont. Res. 22:29-36. http://dx.doi.org/10.1111/j.1600-0765 .1987.tb01536.x.
26. Galli SJ, Borregaard N, Wynn TA. 2011. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Rev. Immunol. 12:1035-1044. http://dx.doi.org/10.1038/ni .2109.
27. Lam RS, O'Brien-Simpson NM, Lenzo JC, Holden JA, Brammar GC, Walsh KA, McNaughtan JE, Rowler DK, Van Rooijen N, Reynolds EC. 28 July 2014. Macrophage depletion abates Porphyromonas gingivalisinduced alveolar bone resorption in mice. J. Immunol. http://dx.doi.org /10.4049/jimmunol.1400853.
28. Westphal O, Jann K. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further application to the procedure p 83. In Whistler RL (ed), Methods in carbohydrate chemistry, vol 5. Academic Press, New York, NY.
29. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622. http://dx.doi.org/10.4049/jimmunol.165.2.618.
30. Chen Y-Y, Peng B, Yang Q, Glew MD, Veith PD, Cross KJ, Goldie KN, Chen D, O'Brien-Simpson N, Dashper SG, Reynolds EC. 2011. The outer membrane protein LptO is essential for the O-deacylation of LPS and the co-ordinated secretion and attachment of A-LPS and CTD proteins in Porphyromonas gingivalis. Mol. Microbiol. 79:1380-1401. http: //dx.doi.org/10.1111/j.1365-2958.2010.07530.x.
31. Curtis MA, Thickett A, Slaney JM, Rangarajan M, Aduse-Opoku J, Shepherd P, Paramonov N, Hounsell EF. 1999. Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect. Immun. 67:3816-3823.
32. Glew MD, Veith PD, Peng B, Chen YY, Gorasia DG, Yang Q, Slakeski N, Chen D, Moore C, Crawford S, Reynolds EC. 2012. PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis. J. Biol. Chem. 287:24605-24617. http://dx.doi.org/10.1074/jbc .M112.369223.
33. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, Hassanzadeh G. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71:597-597. http: //dx.doi.org/10.1371/journal.pone.0031205.
34. Gemmell E, Carter CL, Hart DNJ, Drysdale KE, Seymour GJ. 2002. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol. Immunol. 17:388 -393. http://dx.doi.org/10.1034/j.1399 -302X.2002.170609.x.
35. Pathirana RD, O'Brien-Simpson NM, Reynolds EC. 2010. Host immune responses to Porphyromonas gingivalis antigens. Periodontol. 2000 52: 218-237. http://dx.doi.org/10.1111/j.1600-0757.2009.00330.x.
36. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, Qureshi N, Michalek SM, Vogel SN. 2001. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1477. http://dx.doi.org/10.1128/IAI.69.3.1477-1482.2001.
37. Rangarajan M, Aduse-Opoku J, Paramonov N, Hashim A, Bostanci N, Fraser OP, Tarelli E, Curtis MA. 2008. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J. Bacteriol. 190:2920- 2932. http://dx.doi.org/10.1128/JB.01868-07.
38. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. 2009. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'phosphatase activities. Cell. Microbiol. 11:1587-1599. http://dx.doi.org/10.1111/j .1462-5822.2009.01349.x.
39. Zenobia C, Hasturk H, Nguyen D, Van Dyke TE, Kantarci A, Darveau RP. 2014. Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect. Immun. 82:650-659. http://dx.doi.org/10.1128/IAI.01136 -13.
40. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect. Immun. 72:5041-5051. http: //dx.doi.org/10.1128/IAI.72.9.5041-5051.2004.
41. Kumada H, Haishima Y, Watanabe K, Hasegawa C, Tsuchiya T, Tanamoto K, Umemoto T. 2008. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide. Oral Microbiol. Immunol. 23:60-69. http://dx.doi.org/10.1111/j.1399-302X.2007 .00392.x.
42. Ogawa T, Yagi T. 2010. Bioactive mechanism of Porphyromonas gingivalis lipid A. Periodontol. 2000 54:71-77. http://dx.doi.org/10.1111/j.1600 -0757.2009.00343.x.
43. Ogawa T, Asai Y, Makimura Y, Tamai R. 2007. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front. Biosci. 12:3795-3812. http://dx.doi.org/10.2741/2353.
44. Sawada N, Ogawa T, Asai Y, Makimura Y, Sugiyama A. 2007. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis. Clin. Exp. Immunol. 148:529-536. http://dx.doi.org/10.1111/j.1365-2249.2007.03346.x.
45. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. 2009. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin. Exp. Immunol. 156:479-487. http://dx.doi.org/10.1111/j.1365 -2249.2009.03920.x.
46. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. 2005. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect. Immun. 73:935-943. http://dx .doi.org/10.1128/IAI.73.2.935-943.2005.
47. Tam V, O'Brien-Simpson NM, Chen Y-Y, Sanderson CJ, Kinnear B, Reynolds EC. 2009. The RgpA-Kgp proteinase-adhesin complexes of Por-phyromonas gingivalis inactivate the Th2 cytokines interleukin-4 and interleukin-5 Infect. Immun. 77:1451-1458. http://dx.doi.org/10.1128/IAI .01377-08.
48. O'Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds EC. 2009. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect. Immun. 77:1246-1261. http://dx.doi.org/10.1128/IAI.01038-08.
49. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA, Darveau RP. 2006. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect. Immun. 74:4474- 4485. http://dx.doi.org/10.1128/IAI.01924-05.
50. Curtis MA, Percival RS, Devine D, Darveau RP, Coats SR, Rangarajan M, Tarelli E, Marsh PD. 2011. Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses. Infect. Immun. 79:1187-1193. http://dx.doi.org/10.1128 /IAI.00900-10.
51. Ba¨ckhed F, Normark S, Schweda EKH, Oscarson S, Richter-Dahlfors A. 2003. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microb. Infect. 5:1057-1063. http://dx .doi.org/10.1016/S1286-4579(03)00207-7.
52. Flad H-D, Loppnow H, Rietschel ET, Ulmer AJ. 1993. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187:303-316. http://dx.doi.org/10.1016/S0171-2985(11)80346-3.
53. Diya Z, Lili C, Shenglai L, Zhiyuan G, Jie Y. 2008. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun. 14:99-107. http://dx.doi.org/10.1177 /1753425907088244.
54. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. 2003. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-α in a 2-way relationship. J. Periodontol. 74:97-102. http: //dx.doi.org/10.1902/jop.2003.74.1.97.
55. Papadopoulos G, Weinberg EO, Massari P, Gibson FC, Wetzler LM, Morgan EF, Genco CA. 2013. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss. J.Immunol. 190:1148-1157. http://dx.doi.org/10.4049/jimmunol.1202511.
56. Raes G, Van den Bergh R, De Baetselier P, Ghassabeh GH, Scotton C, Locati M, Mantovani A, Sozzani S. 2005. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174:6561-6562. http://dx.doi.org/10.4049/jimmunol.174.11 .6561.
57. Fleetwood AJAJ, Lawrence T, Hamilton JA, Cook AD. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178:5245-5252. http://dx.doi .org/10.4049/jimmunol.178.8.5245.
58. Sierra-Filardi, E, Vega MA, Sa P, Corbi{dotless} AL, Sa´nchez-Mateos P, Corbi´ AL, Puig-Kro¨ger A. 2010. Heme oxygenase-1 expression in M-CSF-polarizedM2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215: 788-795. http://dx.doi.org/10.1016/j.imbio.2010.05.020.
59. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686. http://dx.doi.org/10.1016/j .it.2004.09.015.
60. Heymann F, Trautwein C, Tacke F. 2009. Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm. Allergy Drug Targets 8:307- 318. http://dx.doi.org/10.2174/187152809789352230.
61. Wynn TA. 2004. Fibrotic disease and the TH1/TH2 paradigm. Nat. Rev. Immunol. 4:583-594. http://dx.doi.org/10.1038/nri1412.
62. Larjava H, Sandberg M, Vuorio E. 1989. Altered distribution of type I collagen mRNA in periodontal disease. J. Periodont. Res. 24:171-177. http://dx.doi.org/10.1111/j.1600-0765.1989.tb02002.x.
63. Chapple CC, Srivastava M, Hunter N. 1998. Failure of macrophage activation in destructive periodontal disease. J. Pathol. 186:281-286.
64. Schlegel Go´mez R, Langer P, Pelka M, Driesch P, Johannessen AC, Simon M, Jr. 1995. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J. Clin. Periodontol. 22:341-346. http://dx.doi .org/10.1111/j.1600-051X.1995.tb00159.x.
65. Foey AD, Crean S. 2013. Macrophage subset sensitivity to endotoxin tolerisation by Porphyromonas gingivalis. PLoS One 8:e67955- e67955. http://dx.doi.org/10.1371/journal.pone.0067955.
66. National Health and Medical Research Council. 2013. Australian code for the care and use of animals for scientific purposes, 8th ed. National Health and Medical Research Council, Canberra, Australia.